That should do it, yep.I am on a daily aspirin regime so...that should cover the blood thining, correct? 81mg taken daily.
That should do it, yep.I am on a daily aspirin regime so...that should cover the blood thining, correct? 81mg taken daily.
Listen to these hearings in Australia.
Also, what the hell is this?
How can people turn a blind eye to this? It's right in our faces.
If they don't support being turned into gene experiments and cattle, that is. Human stupidity, and all.people don't want to admit they were wrong, and leftists expecially would rather die then admit they fucked up.
I recall the EU officials getting a 'special' flu shot about 8-10 years ago.
DEATHWALKER!
We are officially at levels of Jha’dur that shouldn’t even be physically possible.DEATHWALKER!
Sebastiano's team showed that mRNA-based expression of the four Yamanaka factors plus two accessory factors (LIN28 and NANOG) to boost reprogramming efficiency could reverse epigenetic and inflammatory signatures and restore regenerative potential in a range of cell types from aged people—cultured fibroblasts, endothelial cells and chondrocytes. "We have seen this now across almost 20 different human cell types," Sebastiano says.
We are officially at levels of Jha’dur that shouldn’t even be physically possible.
Billionaires Bankroll Cell Rejuvenation Tech as the Latest Gambit to Slow Aging
Start-ups bet that carefully controlled cell reprogramming may lead to age reversal, but hurdles remainwww.scientificamerican.com
Skimming through there, I'm seeing another "We're going to treat people with lipid-based nanoparticles containing mRNA, and that mRNA is going to go only where we intend it to go and do only what we intend it to do."
I wonder when the warm welcomes will run out, and John Campbell's seemingly limitless patience will finally run thin?
Yup. Bad enough to get sued to shit if no political shenanigans shield the culprits, not bad enough to vindicate all the doomers and conspiracy theorists who were talking about 30\60\80\99% killshot, who in turn get used by media as the strawman to discredit the more reasonable dissenters from "safe and effective" narrative.He was saying 1 in 35 with myocardial symptoms the other day.
Holy. Fucking. Shit. This is bad.
I had decided to take a "wait and see" approach because I don't trust big pharma or the government, and both them working together scared the shit out of me.Yup. Bad enough to get sued to shit if no political shenanigans shield the culprits, not bad enough to vindicate all the doomers and conspiracy theorists who were talking about 30\60\80\99% killshot, who in turn get used by media as the strawman to discredit the more reasonable dissenters from "safe and effective" narrative.
I got into an argument with PainRack about this on Discord. He insisted that the vaccine produced Spike proteins that were then busted up into small fragments and presented by MHC, and that it didn't "cover cells in whole Spike protein willy-nilly". He was actually completely wrong about that. The mRNA vaccines absolutely do decorate cells in whole Spike.I had decided to take a "wait and see" approach because I don't trust big pharma or the government, and both them working together scared the shit out of me.
I waited. I saw. I am seeing more now. 1 in 35 is an insanely large number. I wonder how far their federal protections go, because this is fucked up.
I was expecting like 1 in 1000. Which was still bad enough for me not to take it. 1 in 35 is astronomical by comparison.
The end product in host cells expressing these mRNA vaccines is a surface-exposed, membrane-anchored, glycosylated, and trimerized Spike protein resembling the 3-D structure of the native viral Spike protein, to the extent that it interacts with its cognate receptor, hACE2 [22].
In conclusion, it is essential to underline that every human cell that intakes the LNPs and translates the viral protein (in case of the mRNA vaccines), or that gets infected by the adenovirus and expresses and translates the viral protein (in case of the adenovirus‐based vaccines), is inevitably recognized as a threat by the immune system and killed (Figure 1). There are no exceptions to this mechanism. The severity of the resulting damage and the consequences for health depend on the quantity of the cells involved, on the type of tissue and on the strength of the following autoimmune reaction. For instance, if the mRNA contained in the LNPs would get internalized by cardiac myocytes, and such cells would produce the spike protein, the resulting inflammation would likely lead to the necrosis of the myocardium, with an extent proportional to the number of involved cells.
Chikungunya virus (CHIKV) infection causes acute disease characterized by fever, rash and arthralgia, which progresses to severe and chronic arthritis in up to 50% of patients. Moreover, CHIKV infection can be fatal in infants or immunocompromised individuals and has no approved therapy or prevention. This phase 1, first-in-human, randomized, placebo-controlled, proof-of-concept trial conducted from January 2019 to June 2020 evaluated the safety and pharmacology of mRNA-1944, a lipid nanoparticle-encapsulated messenger RNA encoding the heavy and light chains of a CHIKV-specific monoclonal neutralizing antibody, CHKV-24 (NCT03829384). The primary outcome was to evaluate the safety and tolerability of escalating doses of mRNA-1944 administered via intravenous infusion in healthy participants aged 18–50 years. The secondary objectives included determination of the pharmacokinetics of mRNA encoding for CHKV-24 immunoglobulin heavy and light chains and ionizable amino lipid component and the pharmacodynamics of mRNA-1944 as assessed by serum concentrations of mRNA encoding for CHKV-24 immunoglobulin G (IgG), plasma concentrations of ionizable amino lipid and serum concentrations of CHKV-24 IgG. Here we report the results of a prespecified interim analysis of 38 healthy participants who received intravenous single doses of mRNA-1944 or placebo at 0.1, 0.3 and 0.6 mg kg−1, or two weekly doses at 0.3 mg kg−1. At 12, 24 and 48 h after single infusions, dose-dependent levels of CHKV-24 IgG with neutralizing activity were observed at titers predicted to be therapeutically relevant concentrations (≥1 µg ml−1) across doses that persisted for ≥16 weeks at 0.3 and 0.6 mg kg−1 (mean t1/2 approximately 69 d). A second 0.3 mg kg−1 dose 1 week after the first increased CHKV-24 IgG levels 1.8-fold. Adverse effects were mild to moderate in severity, did not worsen with a second mRNA-1944 dose and none were serious. To our knowledge, mRNA-1944 is the first mRNA-encoded monoclonal antibody showing in vivo expression and detectable ex vivo neutralizing activity in a clinical trial and may offer a treatment option for CHIKV infection. Further evaluation of the potential therapeutic use of mRNA-1944 in clinical trials for the treatment of CHIKV infection is warranted.
Fucking monsters, the lot of them.All a part of the plan.
Bill Gates and his reduce the population by 15 percent with vaccines plan. Or something to that effect.
The elites never hid it. They think overpopulation is a thing and want to "fix" it.